Drug Investigation to Dampen the Comorbidity of Rheumatoid Arthritis and Osteoporosis via Molecular Docking Test

At present, most rheumatoid arthritis (RA) patients are at risk of osteoporosis (OP), which is increased by 1.5 times compared to non-RA individuals. Hence, we investigated overlapping targets related directly to the occurrence and development of RA and OP through public databases (DisGeNET, and OMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Ki-Kwang, Adnan, Md., Cho, Dong-Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947408/
https://www.ncbi.nlm.nih.gov/pubmed/35723292
http://dx.doi.org/10.3390/cimb44030069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947408/
https://www.ncbi.nlm.nih.gov/pubmed/35723292
http://dx.doi.org/10.3390/cimb44030069

Ejemplares similares